ADAMTS13 and thrombotic thrombocytopenic purpura: In these patients, the association of severe ADAMTS-13 deficiency and the presence of anti-ADAMTS-13 autoantibodies have been reported as the most negative prognostic markers at remission, increasing the relative risk of TTP recurrence by 3.6 times [12,13].